Stay updated on Sublingual Dexmedetomidine in Schizophrenia-Associated Agitation Clinical Trial

Sign up to get notified when there's something new on the Sublingual Dexmedetomidine in Schizophrenia-Associated Agitation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sublingual Dexmedetomidine in Schizophrenia-Associated Agitation Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A notice about NIH’s terminology transition appears above the study page. The study record itself remains unavailable and displays a 403 error.
    Difference
    1%
    Check dated 2026-10-25T06:52:05.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-18T05:21:12.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer’s displayed ClinicalTrials.gov revision changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T08:30:00.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error page, replacing the previous content with an access-denied view. A Home button is presented on the error page.
    Difference
    0.5%
    Check dated 2026-09-27T07:51:02.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error page for the study record URL, indicating access is blocked and displaying a 403 header and related message. The usual study details are not visible, replaced by the error screen with a Home option.
    Difference
    18%
    Check dated 2026-09-20T03:15:00.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6, replacing the previous Revision: v3.6.5, indicating a minor metadata update to the study record.
    Difference
    0.1%
    Check dated 2026-08-29T20:02:29.000Z thumbnail image

Stay in the know with updates to Sublingual Dexmedetomidine in Schizophrenia-Associated Agitation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sublingual Dexmedetomidine in Schizophrenia-Associated Agitation Clinical Trial page.